A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy
Nivolumab and ipilimumab are widely used immune checkpoint inhibitors (ICPIs) for the treatment of metastatic melanoma. ICPIs cause an array of side effects called immune-related adverse events (IRAEs) due to activation of an immune response. ICPI-uveitis can cause irreversible vision loss if untrea...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Karger Publishers
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/bdda95afbe8143d7ab45e5aea2cdd0ce |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|